A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2).

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1016/j.ijgc.2025.102654

A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2).

Ramez N. Eskander & Nicoletta Colombo et al. · 2025

Links

DOI

Journal

Unknown Journal

Authors

Ramez N. Eskander, Bradley Corr, David Cibula, David S.P. Tan, Noelle Cloven, Eva Guerra, Kosei Hasegawa, Tashanna Myers, Benoit You, Vicky Makker, Flora Zagouri, Lilian T. Gien, Michele Bartoletti, Adrianne Mallen, Linn Woelber, Simonetta Mocci, Kimberly Komatsubara, Long Ma, Nicoletta Colombo